Alan J. Hirschfield is Director at CANTEL MEDICAL CORP (CMN). They have made 15 open-market trades across 3 companies since 2006, most recently 2014-10-27.
CIK 0000941417
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
7 open-market purchases totalling $744K since 2006, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CMN | SELL | 2014-10-17 | 2014-10-20 | $36.98 | $740K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2014-10-14 | 2014-10-16 | $37.73 | $1.9M | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2012-06-29 | 2012-07-05 | $27.39 | $433K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2012-06-28 | 2012-07-02 | $26.00 | $51K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2012-06-19 | 2012-06-21 | $27.21 | $877K | -7.1% | -3.4% | -3.4% |
| CMN | SELL | 2011-04-20 | 2011-04-21 | $26.17 | $20K | -7.1% | -3.4% | -3.4% |
| LUK | SELL | 2011-03-16 | 2011-03-17 | $33.42 | $134K | -9.6% | -0.1% | -0.1% |
| CKEC | BUY | 2010-08-13 | 2010-08-16 | $6.40 | $13K | N/A | N/A | N/A |
| CKEC | BUY | 2010-08-12 | 2010-08-13 | $6.50 | $52K | N/A | N/A | N/A |
| CKEC | BUY | 2010-08-10 | 2010-08-11 | $6.55 | $66K | N/A | N/A | N/A |
| CKEC | BUY | 2010-06-11 | 2010-06-16 | $7.39 | $117K | N/A | N/A | N/A |
| CKEC | BUY | 2010-06-09 | 2010-06-16 | $7.62 | $111K | N/A | N/A | N/A |
| CMN | SELL | 2009-01-15 | 2009-01-16 | $14.64 | $513K | -7.1% | -3.4% | -3.4% |
| LUK | BUY | 2006-08-24 | 2006-08-25 | $25.31 | $127K | -9.6% | -0.1% | -0.1% |
| LUK | BUY | 2006-08-22 | 2006-08-23 | $25.83 | $258K | -9.6% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.